​

BridgeBio Pharma Ownership | Who Owns BridgeBio Pharma?

OverviewForecastRevenueFinancialsChartTranscripts

BridgeBio Pharma Ownership Summary

BridgeBio Pharma is owned by 100.20% institutional investors, 3.93% insiders. Vanguard group is the largest institutional shareholder, holding 8.85% of BBIO shares. Blue Owl Credit Income Corp D is the top mutual fund, with 3.89% of its assets in BridgeBio Pharma shares.

BBIO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockBridgeBio Pharma100.20%3.93%-4.13%
SectorHealthcare Stocks 245.07%12.10%-157.17%
IndustryBiotech Stocks 380.48%11.73%-292.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group16.86M8.85%$1.29B
Kohlberg kravis roberts13.26M6.81%$987.68M
Janus henderson group13.18M6.68%$978.61M
Blackrock12.45M6.64%$315.31M
Farallon capital management10.74M5.52%$800.14M
Blackrock funding, inc. /de10.29M5.28%$766.19M
Viking global investors lp9.95M5.11%$741.02M
Vanguard capital management7.90M4.06%$588.32M
Wellington management group llp5.31M2.73%$395.41M
Two sigma investments, lp4.72M2.42%$351.71M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Aisling capital management lp4.59M72.48%$341.83M
Kohlberg kravis roberts13.26M17.30%$987.68M
Catalio capital management, lp455.04K6.37%$33.89M
Cutter capital management, lp560.34K6.30%$15.38M
Boone capital management339.72K5.92%$25.30M
First turn management633.36K5.05%$47.17M
Superstring capital management lp88.66K4.54%$4.60M
Farallon capital management10.74M3.69%$800.14M
Knott david m jr92.85K3.66%$6.92M
Fernwood investment management278.33K2.66%$7.64M

Top Buyers

HolderShares% AssetsChange
Wellington management group llp5.31M0.07%2.82M
Janus henderson group13.18M0.49%2.18M
Blackrock12.45M0.01%1.98M
Sixth street partners management company1.71M0.02%1.71M
Norges bank1.69M0.01%1.69M

Top Sellers

HolderShares% AssetsChange
Blackrock funding, inc. /de10.29M0.01%-3.92M
Brooklands fund management---2.75M
Price t rowe associates inc /md/1.73M0.01%-2.08M
Frazier life sciences management1.55M2.51%-1.90M
Viking global investors lp9.95M2.11%-1.89M

New Positions

HolderShares% AssetsChangeValue
Sixth street partners management company1.71M0.02%1.71M$127.32M
Norges bank1.69M0.01%1.69M$126.15M
Point72 asset management1.53M0.13%1.53M$113.64M
T. rowe price investment management1.05M0.03%1.05M$54.63M
Longaeva partners187.86K0.31%187.86K$13.99M

Sold Out

HolderChange
Dv trading-1.00
Tortoise investment management-1.00
Dunhill financial-2.00
Central trust-2.00
Td private client wealth-2.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20265052.43%195,177,9420.27%1001.00%250-8.42%17627.54%
Mar 31, 20264831.90%193,076,3051.05%970.97%2621.16%138-
Dec 31, 2025140-67.21%32,651,635-82.36%170.18%86-61.78%32-76.30%
Sep 30, 2025144-63.36%28,301,584-85.01%140.15%78-65.64%46-57.80%
Jun 30, 202539213.29%188,775,9601.99%991.05%22614.14%10932.93%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Blue Owl Credit Income Corp D7.62M3.89%7.62M
Vanguard MStar Total Stk Mkt Idx Invest5.62M2.87%17.24K
Vanguard Total Stock Mkt Idx Inv5.60M2.86%42.48K
Vanguard Morn Total Stk Mkt Idx Investor5.60M2.86%42.48K
Vanguard US Total Market Shares ETF4.53M2.38%3.92K
Vanguard Small Cap Index4.05M2.07%7.94K
iShares Russell 2000 ETF3.80M1.94%35.05K
Vanguard Health Care Inv2.64M1.35%2.64M
SPDR® S&P Biotech ETF2.40M1.26%5.36K
Vanguard MStar Small Cap Growth Indx Inv2.34M1.20%7.83K

Recent Insider Transactions

DateNameRoleActivityValue
Sep 17, 2026Kumar Neil Chief Executive OfficerSell$88.98K
Sep 17, 2026Kumar Neil Chief Executive OfficerSell$601.87K
Aug 18, 2026Kumar Neil Chief Executive OfficerSell$154.18K
Aug 19, 2026Kumar Neil Chief Executive OfficerSell$152.44K
Aug 19, 2026Kumar Neil Chief Executive OfficerSell$679.26K

Insider Transactions Trends

DateBuySell
2026 Q3-11
2026 Q2-52
2026 Q1-50
2025 Q4-50
2025 Q3-35

BBIO Ownership FAQ

Who Owns BridgeBio Pharma?

BridgeBio Pharma shareholders are primarily institutional investors at 100.20%, followed by 3.93% insiders and -4.13% retail investors. The average institutional ownership in BridgeBio Pharma's industry, Biotech Stocks , is 380.48%, which BridgeBio Pharma falls below.

Who owns the most shares of BridgeBio Pharma?

BridgeBio Pharma’s largest shareholders are Vanguard group (16.86M shares, 8.85%), Kohlberg kravis roberts (13.26M shares, 6.81%), and Janus henderson group (13.18M shares, 6.68%). Together, they hold 22.34% of BridgeBio Pharma’s total shares outstanding.

Does Blackrock own BridgeBio Pharma?

Yes, BlackRock owns 6.64% of BridgeBio Pharma, totaling 12.45M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 315.31M$. In the last quarter, BlackRock increased its holdings by 1.98M shares, a 18.93% change.

Who is BridgeBio Pharma’s biggest shareholder by percentage of total assets invested?

Aisling capital management lp is BridgeBio Pharma’s biggest shareholder by percentage of total assets invested, with 72.48% of its assets in 4.59M BridgeBio Pharma shares, valued at 341.83M$.

Who is the top mutual fund holder of BridgeBio Pharma shares?

Blue Owl Credit Income Corp D is the top mutual fund holder of BridgeBio Pharma shares, with 3.89% of its total shares outstanding invested in 7.62M BridgeBio Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools